Search

Search Constraints

You searched for: Author/Creator Stoehr, Albrecht

Search Results

1. 1981. Real-World Data on Safety and Effectiveness of Glecaprevir/Pibrentasvir for the Treatment of Patients With Chronic Hepatitis C Virus Infection on Opioid Substitution Therapy: Latest Results from the German Hepatitis C-Registry. (26th November 2018)

2. CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma. (13th March 2016)

3. CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma. (13th March 2016)

4. Efficacy and safety of sofosbuvir-based triple therapy in hepatitis C genotype 4 infection. Issue 9 (September 2015)

5. Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study. (13th August 2020)

6. Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry. (1st March 2021)

7. Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R). Issue 1 (January 2022)

8. Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study. Issue 2 (30th September 2021)

9. Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy. Issue 4 (3rd April 2021)

10. Real‐world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C‐Registry. Issue 8 (15th March 2019)